Harding Thomas C.'s Form 4 filing
Clovis Oncology, Inc. (CLVS) · filed Nov 3, 2021
- Accession no.
- 0000899243-21-042704
- Filed
- Nov 3, 2021
- Trade date
- Nov 1-2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.94K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harding Thomas C.CIK 0001834833 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +1,562 | –F1 | – | 5,125 | Direct | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −779 | $4.55 | −$3,544.45 | 4,346 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +1,812 | –F1 | – | 6,158 | Direct | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −903 | $4.55 | −$4,108.65 | 5,255 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +181 | –F1 | – | 1,593 | Indirect | |
| Nov 2, 2021 | Common Stock | SSaleDisposed | −62 | $4.55 | −$282.1 | 1,531 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −1,562 | $0.00 | $0 | 7,813 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −1,812 | $0.00 | $0 | 16,313 | Direct | |
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −181 | $0.00 | $0 | 1,632 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each Restricted Stock Unit represents the right to receive one share of Common Stock.
Referenced by the price of 3 transactions in Table I.
Remarks
Senior Vice President and Chief Scientific Officer